An alkaloid with diverse biological activities
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Matrine

Item No. 22901

Technical Information
Formal Name
(7aS,13aR,13bR,13cS)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one
CAS Number
519-02-8
Synonyms
  • NSC 146051
  • NSC 318810
Molecular Formula
C15H24N2O
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 33.3 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
O=C1CCC[C@@]2([H])N1C[C@@]3([H])[C@@]4([H])[C@]2([H])CCCN4CCC3
InChi Code
InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12+,13+,15-/m0/s1
InChi Key
ZSBXGIUJOOQZMP-JLNYLFASSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Matrine is an alkaloid found in S. flavescens roots that has diverse biological activities. It inhibits LPS-induced splenocyte proliferation and release of IL-1 and IL-6 from mouse peritoneal macrophages in vitro.1 In mice, administration of matrine inhibits the development of LPS-induced hepatitis in a dose-dependent manner.2 Matrine reduces production of the hepatitis B surface antigen (HBsAG) and serum antigen (HBeAG) with IC50 values of 0.75 and 3.35 mg/mL, respectively, in vitro and inhibits viral replication in a duck model of hepatitis B.3 In vitro, matrine inhibits angiotension II-induced hyperplastic growth of cardiac fibroblasts in a dose-dependent manner.4 Matrine also inhibits proliferation of melanoma, breast, and colon cancer cells with IC50s ranging from 0.769-2.758 mg/ml.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hu, Z.-L., Zhang, J.-P., Qian, D.-H., et alEffects of matrine on mouse splenocyte proliferation and release of interleukin-1 and -6 from peritoneal macrophages in vitro. Zhongguo Yao Li Xue Bao. 17(3), 259-261 (1996).

    2. Hu, Z.-L., Zhang, J.-P., Yu, X.-B., et alEffect of matrine on lipopolysaccharides/D-galactosamine-induced hepatitis and tumor necrosis factor release from macrophages in vitro. Zhongguo Yao Li Xue Bao. 17(4), 351-353 (1996).

    3. Li, C.-Q., Zhu, Y.-T., Zhang, F.-X., et alAnti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J. Gastroenterol. 11(3), 426-428 (2005).

    4. Li, Y., Wang, B., Zhou, C., et alMatrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: Effects on Bcl-2/Bax expression and caspase-3 activation. Basic Clin. Pharmacol. Toxicol. 101(1), 1-8 (2007).

    5. Jin, H., Sun, Y., Wang, S., et alMatrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells. Int. J. Mol. Sci. 14(8), 16040-16057 (2013).